Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Parenting and CAH - 21-hydroxylase Deficiency Start date moved earlier from Mar 16, 2026 to Mar 13, 2026
- Minor: Empowering the Clinical Management of BMFs Through a Biological and Genetically Driven Pediatric and Adult National Network Study completion pushed from Dec 31, 2026 to Feb 28, 2027
- Minor: Addressing Spasticity and Motor Function With Epidural Spinal Cord Stimulation Start date changed from estimate of Oct 1, 2026 to Nov 1, 2026
- Minor: Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS Based on the Mobile Application Start date changed from estimate of Sep 28, 2026 to Oct 7, 2026
- Minor: NEURO-COGS · Neurometabolic Mechanisms of Cognitive Training in Schizophrenia Start date pushed from Nov 16, 2026 to Nov 30, 2026
- Minor: Acute Hospital Care at Home · Dementia Start date pushed from Nov 17, 2026 to Dec 1, 2026
- Minor: Hospital Initiation of Inclisiran Treatment · Acute Coronary Syndromes Enrollment closed, study ongoing
- Minor: BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment · EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04) Enrollment closed, study ongoing
- Minor: 5% Minoxidil Foam in Female Androgenetic Alopecia Trial completed
- Minor: Brivaracetam in Children and · Seizures Enrollment closed, study ongoing
- Minor: IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia Trial completed
- Minor: Enlicitide · High Cholesterol (MK-0616-037) Trial completed
- Minor: PYLARIFY® PET/CT or PET/MRI · Favorable Intermediate Risk (FIR) Prostate Cancer Trial completed
- Minor: Persistence of ACE1831, · IgG4-Related Disease Enrollment closed, study ongoing
- Minor: Gene Therapy Drug · Spinal Muscular Atrophy (SMA) Type 2 Patients Trial completed
- Minor: CRB-601-01 · Advanced Solid Tumor Trial completed
- Minor: ARV-806 · Advanced Cancer That Has the KRAS G12D Mutation Trial completed
- Minor: Basket Study of Entrectinib (RXDX-101) · Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Trial completed
- Minor: Tirbanibulin for Pediatric Warts Trial completed
- Minor: ENV-101 · Lung Fibrosis (WHISTLE-PF Trial) Trial completed
- Minor: Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, · Obesity or Overweight Trial completed
- Minor: Eloralintide (LY3841136) in Healthy Participants Trial completed
- Minor: Eloralintide (LY3841136) · Obesity or Overweight Enrollment closed, study ongoing
- Minor: Gene Therapy Drug · Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis Enrollment closed, study ongoing
- Minor: SL-325 in Healthy Volunteers Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates